Groundbreaking Research from Johns Hopkins Uncovers Key Neural Mechanisms
Researchers at Johns Hopkins University have published new findings demonstrating how specific neurons expressing the neuropeptide cortistatin in the prelimbic cortex influence seizure susceptibility, with pronounced effects observed in female mice. The study, led by Aaron J. Salisbury, Lourdes Figueroa, Keri Martinowich, and Michael S. Totty, highlights a potential shared pathway between epilepsy and stress-related psychiatric conditions such as major depressive disorder and post-traumatic stress disorder.
The work centers on cortistatin-positive (CST+) GABAergic neurons, which play a role in maintaining balanced brain activity. Disruptions in these cells within the prelimbic cortex, a region analogous to the human dorsal anterior cingulate cortex, led to increased seizure vulnerability and altered fear processing in experimental models.
Understanding the Prelimbic Cortex and Cortistatin Neurons
The prelimbic cortex serves as a critical hub for processing contextual information related to fear and decision-making. Cortistatin, a neuropeptide structurally related to somatostatin, is expressed in a subset of inhibitory neurons that help regulate excitatory signaling. These CST+ cells often co-express markers such as somatostatin or parvalbumin and are concentrated in cortical areas.
In the study, selective ablation of these neurons using targeted viral approaches resulted in spontaneous convulsive seizures in some animals. Mice also exhibited heightened sensitivity to chemical convulsants, with the ablation group showing dramatically elevated seizure severity compared to controls.
Experimental Approaches and Key Findings on Seizure Susceptibility
Investigators employed genetic tools to ablate CST+ neurons specifically in the prelimbic cortex of adult mice. Behavioral assessments included auditory fear conditioning paradigms to evaluate fear acquisition, extinction, and renewal. Open-field tests measured locomotion and anxiety-like behaviors.
Results showed that while basic fear learning remained intact, context-dependent fear renewal was impaired following ablation. Spontaneous seizures emerged in a subset of ablated animals, and administration of a subthreshold dose of pentylenetetrazol triggered fatal seizures exclusively in the ablation group. Chemogenetic inhibition of these neurons further accelerated seizure kindling progression, particularly in females.
Sex-Specific Effects Involving BDNF–TrkB Signaling
A notable aspect of the research involves brain-derived neurotrophic factor (BDNF) signaling through its receptor TrkB. Disrupting this pathway within CST+ neurons mirrored the effects of direct inhibition, increasing kindling rates selectively in female mice. This points to a sexually dimorphic role for BDNF–TrkB in maintaining cortical excitability.
BDNF supports the development and function of GABAergic neurons, and its dysregulation has been linked to various neurological conditions. The findings suggest that CST+ neuron integrity, modulated by this signaling axis, helps restrain hyperexcitability in a sex-dependent manner.
Photo by Bioscience Image Library by Fayette Reynolds on Unsplash
Connections to Psychiatric Disorders and Epilepsy Comorbidity
Patients with epilepsy face a threefold higher risk of developing post-traumatic stress disorder, while individuals with PTSD show elevated epilepsy rates. Shared disruptions in GABAergic inhibition may underlie these overlaps. Prior work from the same research group identified downregulation of the cortistatin gene in the dorsal anterior cingulate cortex of individuals with major depressive disorder or PTSD.
The current study provides mechanistic support for how loss of CST+ neuron function could contribute to both cortical hyperexcitability and dysregulated fear responses, offering insights into why these conditions frequently co-occur.
Implications for Neuroscience Research and Therapeutic Development
These results underscore the importance of examining specific neuronal subpopulations rather than broad categories of inhibitory cells. Targeting cortistatin-expressing neurons or enhancing BDNF–TrkB signaling in these populations could represent novel avenues for addressing seizure disorders, especially those with sex-specific presentations.
The research also emphasizes the value of integrating findings from animal models with human postmortem data to identify conserved mechanisms across species.
Opportunities for Academics and Emerging Researchers in the Field
Studies like this highlight expanding frontiers in neuroscience, particularly at the intersection of epilepsy, stress biology, and molecular signaling. Institutions such as Johns Hopkins continue to lead in training the next generation of investigators equipped to tackle these complex questions.
Graduate students and postdoctoral researchers interested in GABAergic circuitry, neuropeptide function, or sex differences in brain disorders may find relevant positions through specialized academic job platforms. Faculty roles in departments of neuroscience, psychiatry, and biostatistics often seek candidates with expertise in circuit-level manipulations and behavioral phenotyping.
Further exploration of these pathways could inform clinical research initiatives aimed at personalized interventions based on biological sex and genetic profiles.
Future Directions and Broader Impact
Additional investigations are needed to determine whether similar mechanisms operate in other brain regions or across different seizure models. Translating these preclinical observations to human populations will require careful validation using imaging, genetic association studies, and clinical cohorts.
The work contributes to a growing body of evidence that precise modulation of inhibitory networks holds promise for treating disorders characterized by both hyperexcitability and emotional dysregulation. Academic communities are encouraged to build on these foundations through collaborative, interdisciplinary efforts.
Photo by Robina Weermeijer on Unsplash
Accessing the Original Publication
The full study appears in Neurobiology of Disease and is available via the publisher's platform. Readers can review the detailed methods, supplementary data, and discussion at the original publication. The authors are credited as Aaron J. Salisbury, Lourdes Figueroa, Keri Martinowich, and Michael S. Totty, with affiliations at Johns Hopkins University institutions.
